Akorn Inc (AKRX):企業の財務・戦略的SWOT分析

◆英語タイトル:Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1670
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Akorn Inc (AKRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including oral liquids, otics, ophthalmics, injectables, topicals, inhalants, and nasal sprays. It also offers contract manufacturing services. Akorn caters to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations and other pharmaceutical companies. The company has manufacturing facilities in India and the US. It operates in the US, Canada, Mauritius, Luxembourg, Switzerland and India. Akorn is headquartered in Lake Forest, Illinois, the US.

Akorn Inc Key Recent Developments

Feb 26,2020 Akorn provides fourth quarter and full year 2019 results
Oct 31,2019 Akorn provides preliminary third quarter 2019 results
Aug 01,2019 Akorn provides preliminary second quarter 2019 results
Jul 30,2019 Akorn signs $74m settlement with investors over data integrity problems

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Akorn Inc – Key Facts
Akorn Inc – Key Employees
Akorn Inc – Key Employee Biographies
Akorn Inc – Major Products and Services
Akorn Inc – History
Akorn Inc – Company Statement
Akorn Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Akorn Inc – Business Description
Business Segment: Consumer Health
Overview
Performance
Business Segment: Prescription Pharmaceuticals
Overview
Performance
Akorn Inc – Corporate Strategy
Akorn Inc – SWOT Analysis
SWOT Analysis – Overview
Akorn Inc – Strengths
Akorn Inc – Weaknesses
Akorn Inc – Opportunities
Akorn Inc – Threats
Akorn Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Akorn Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 26, 2020: Akorn provides fourth quarter and full year 2019 results
Oct 31, 2019: Akorn provides preliminary third quarter 2019 results
Aug 01, 2019: Akorn provides preliminary second quarter 2019 results
Jul 30, 2019: Akorn signs $74m settlement with investors over data integrity problems
Jun 25, 2019: Akorn receives FDA warning letter related to the inspection of its Somerset, New Jersey manufacturing facility
Jun 13, 2019: Akorn receives warning letter from FDA
May 07, 2019: Akorn provides preliminary first quarter 2019 results and full year guidance
Mar 21, 2019: Akorn names Erislandy (Dandy) Dorado-Boladeres as executive vice president of global quality
Mar 01, 2019: Akorn comments on favorable court order
Feb 28, 2019: Akorn provides fourth quarter and full year 2018 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Akorn Inc, Key Facts
Akorn Inc, Key Employees
Akorn Inc, Key Employee Biographies
Akorn Inc, Major Products and Services
Akorn Inc, History
Akorn Inc, Other Locations
Akorn Inc, Subsidiaries
Akorn Inc, Joint Venture
Akorn Inc, Key Competitors
Akorn Inc, Ratios based on current share price
Akorn Inc, Annual Ratios
Akorn Inc, Annual Ratios (Cont...1)
Akorn Inc, Annual Ratios (Cont...2)
Akorn Inc, Interim Ratios
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Akorn Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Akorn Inc, Performance Chart (2015 - 2019)
Akorn Inc, Ratio Charts
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Akorn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Akorn Inc (AKRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alert Logic Inc:企業の戦略的SWOT分析
    Alert Logic Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • AB Sciex LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary AB Sciex LLC (Sciex), a subsidiary of Danaher Corp, is a provider of life science analytical technologies. The company provides mass spectrometry solutions combined with capillary electrophoresis and liquid chromatography. Its product portfolio includes liquid chromatography-mass spectromete …
  • Range Energy Resources Inc (RGO):石油・ガス:M&Aディール及び事業提携情報
    Summary Range Energy Resources Inc (Range Energy), formerly Hawkstone Energy Corp, is an oil and gas company that offers exploration and development services. The company acquires, explores and produces minerals, and oil and gas resource properties. It holds interests in Khalakan Production Sharing …
  • Noble Energy Inc (NBL)-石油・ガス分野:企業M&A・提携分析
    Summary Noble Energy, Inc. (Noble Energy) is an independent energy company that explores for and produces crude oil, natural gas and natural gas liquids (NGLs). The company’s portfolio includes both US unconventional and global offshore conventional assets in various countries. Noble Energy has oper …
  • Arno Therapeutics Inc (ARNI)-製薬・医療分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Anaconda Mining Inc:企業の戦略・SWOT・財務情報
    Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Powerco Ltd:企業の戦略的SWOT分析
    Powerco Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • OAO Gazprom:企業の戦略・SWOT・財務情報
    OAO Gazprom - Strategy, SWOT and Corporate Finance Report Summary OAO Gazprom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Breckenridge Pharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Breckenridge Pharmaceutical Inc (Breckenridge), a subsidiary of Laboratorios Del Dr Esteve SA, is a healthcare solution provider that research, develops and markets various generic prescription products. The company offers products such as stradiol, oxcarbazepine tablets, methylprednisolone, …
  • Datalogic SpA (DAL):企業の財務・戦略的SWOT分析
    Datalogic SpA (DAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Schiller AG:企業の戦略的SWOT分析
    Schiller AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • RPC Group PLC:企業のM&A・事業提携・投資動向
    RPC Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RPC Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Flex Ltd (FLEX):企業の財務・戦略的SWOT分析
    Flex Ltd (FLEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Thermo Fisher Scientific Inc.:企業のM&A・事業提携・投資動向
    Thermo Fisher Scientific Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Thermo Fisher Scientific Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Cold Spring Harbor Laboratory:製薬・医療:M&Aディール及び事業提携情報
    Summary Cold Spring Harbor Laboratory (CSHL) is a research and education institution that offers molecular biology and genetics services. The institution offers research services such as graduate research, research training, clinical research, quantitative biology research, postdoctoral research, di …
  • Otis Elevator Co:企業の戦略・SWOT・財務情報
    Otis Elevator Co - Strategy, SWOT and Corporate Finance Report Summary Otis Elevator Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NiSource Inc.:企業の戦略・SWOT・財務分析
    NiSource Inc. - Strategy, SWOT and Corporate Finance Report Summary NiSource Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • CML Microsystems PLC (CML):企業の財務・戦略的SWOT分析
    Summary CML Microsystems Plc (CML Microsystems) is an electronic equipment provider that designs, manufactures and markets mixed-signal and radio frequency semiconductors. The company provides integrated circuits that offer voice, data, signaling, and radio frequency requirements for military commun …
  • Industrias Penoles SAB de CV:戦略・SWOT・企業財務分析
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SeaWorld Entertainment Inc:戦略・SWOT・企業財務分析
    SeaWorld Entertainment Inc - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆